Search

Huining Kang

from Albuquerque, NM
Age ~66
Get Report
Also known as:
Hui Ning Kang, Hulnin Kang, Hui-Ning Kang, Kang Huining, G Kang
Phone and address:
1131 Titleist Dr, Albuquerque, NM 87112
(505) 293-2613
Related to:
Kang KeunsXuan Kang, 38Xuan Kang
Connected to:
Ai Kang, 38Amanpreet Kang, 64Ana E Kang, 42Austina W Kang, 39Baek S Kang, 56Bang I Kang, 84Bruce Kang, 63Byungkyu Kang, 43Byungmin Kang, 34Carolyn E Kang, 50

Huining Kang Phones & Addresses

  • 1131 Titleist Dr, Albuquerque, NM 87112 (505) 293-2613
  • 402 Cornell Dr, Albuquerque, NM 87106 (505) 266-3419
  • 949 Buena Vista Ave, Albuquerque, NM 87106 (505) 246-2098
  • 11800 Montgomery Blvd, Albuquerque, NM 87111 (505) 293-2613
  • Milwaukee, WI
  • Waynesburg, PA
  • Bernalillo, NM
  • 1131 Titleist Dr NE, Albuquerque, NM 87112

Work

Company: The university of new mexico school of medicine Aug 2004 Position: Associate professor

Education

Degree: Doctorates, Doctor of Philosophy School / High School: The University of New Mexico 2001 to 2006 Specialities: Statistics, Philosophy

Industries

Higher Education

Resumes

Resumes

Huining Kang Photo 1

Associate Professor

View page
Location:
Albuquerque, NM
Industry:
Higher Education
Work:
The University of New Mexico School of Medicine
Associate Professor
Education:
The University of New Mexico 2001 - 2006
Doctorates, Doctor of Philosophy, Statistics, Philosophy

Publications

Us Patents

Outcome Prediction And Risk Classification In Childhood Leukemia

View page
US Patent:
20090203588, Aug 13, 2009
Filed:
Jun 8, 2007
Appl. No.:
11/811436
Inventors:
Cheryl L. Willman - Albuquerque NM, US
Paul Helman - Albuquerque NM, US
Robert Veroff - Albuquerque NM, US
George S. Davidson - Albuquerque NM, US
Shawn B. Martin - Albuquerque NM, US
Susan R. Atlas - Albuquerque NM, US
Erik Andries - Rio Rancho NM, US
Huining Kang - Albuquerque NM, US
Jonathan J. Shuster - Gainesville FL, US
Xuefei Wang - Albuquerque NM, US
Richard C. Harvey - Placitas NM, US
David M. Haaland - Albuquerque NM, US
Jeffrey W. Potter - Albuquerque NM, US
International Classification:
A61K 38/17
C12N 15/12
C07H 21/04
C07K 14/47
A61K 31/711
A61P 35/02
C12N 5/10
C12N 15/85
C12Q 1/68
G01N 33/566
US Classification:
514 12, 536 235, 536 245, 530350, 4353201, 435 6, 435 71, 514 44, 435325
Abstract:
Genes and gene expression profiles useful for predicting outcome, risk classification, cytogenetics and/or etiology in pediatric acute lymphoblastic leukemia (ALL). OPAL1 is a novel gene associated with outcome and, along with other newly identified genes, represent a novel therapeutic targets.

Gene Expression Classifiers For Relapse Free Survival And Minimal Residual Disease Improve Risk Classification And Outcome Prediction In Pediatric B-Precursor Acute Lymphoblastic Leukemia

View page
US Patent:
20110230372, Sep 22, 2011
Filed:
Nov 16, 2009
Appl. No.:
12/998474
Inventors:
Cheryl L. Willman - Albuquerque NM, US
Richard Harvey - Placitas NM, US
Huining Kang - Albuquerque NM, US
Edward Bedrick - Albuquerque NM, US
Xuefei Wang - Creve Coeur MO, US
Susan R. Atlas - Albuquerque NM, US
I-Ming Chen - Albuquerque NM, US
International Classification:
C40B 40/06
C12Q 1/68
G01N 33/566
C12Q 1/44
C12Q 1/527
C12Q 1/48
G01N 33/573
US Classification:
506 16, 435 618, 435 617, 435 616, 435 61, 435 792, 435 19, 435 4, 435 15, 435 613, 435 71, 436501
Abstract:
The present invention relates to the identification of genetic markers patients with leukemia, especially including acute lymphoblastic leukemia (ALL) at high risk for relapse, especially high risk B-precursor acute lymphoblastic leukemia (B-ALL) and associated methods and their relationship to therapeutic outcome. The present invention also relates to diagnostic, prognostic and related methods using these genetic markers, as well as kits which provide microchips and/or immunoreagents for performing analysis on leukemia patients.

Outcome Prediction And Risk Classification In Childhood Leukemia

View page
US Patent:
20060063156, Mar 23, 2006
Filed:
Dec 5, 2003
Appl. No.:
10/729895
Inventors:
Cheryl Willman - Albuquerque NM, US
Paul Helman - Albuquerque NM, US
Robert Veroff - Albuquerque NM, US
George Davidson - Albuquerque NM, US
Shawn Martin - Albuquerque NM, US
Susan Atlas - Albuquerque NM, US
Erik Andries - Rio Rancho NM, US
Huining Kang - Albuquerque NM, US
Jonathan Shuster - Gainesville FL, US
Xuefei Wang - Albuquerque NM, US
Richard Harvey - Placitas NM, US
David Haaland - Albuquerque NM, US
Jeffrey Potter - Albuquerque NM, US
International Classification:
C12Q 1/68
C07H 21/04
C12P 21/06
C12N 15/09
C07K 14/705
US Classification:
435006000, 435069100, 435320100, 435325000, 530350000, 536023200
Abstract:
Genes and gene expression profiles useful for predicting outcome, risk classification, cytogenetics and/or etiology in pediatric acute lymphoblastic leukemia (ALL). OPAL1 is a novel gene associated with outcome and, along with other newly identified genes, represent a novel therapeutic targets.

Gene Expression Signatures For Detection Of Underlying Philadelphia Chromosome-Like (Ph-Like) Events And Therapeutic Targeting In Leukemia

View page
US Patent:
20200318197, Oct 8, 2020
Filed:
Dec 18, 2019
Appl. No.:
16/719497
Inventors:
- Albuquerque NM, US
- Memphis TN, US
- Philadelphia PA, US
I-Ming Chen - Albuquerque NM, US
Kathryn G. Roberts - Memphis TN, US
Huining Kang - Albuquerque NM, US
Richard C. Harvey - Placitas NM, US
International Classification:
C12Q 1/6886
Abstract:
The invention provides arrays, systems, devices, methods, computer-readable media and kits that enable expression-based classification of B-precursor acute lymphoblastic leukemia (ALL) as being either responsive or non-responsive to tyrosine kinase inhibitor mono or co-therapy.

Gene Expression Signatures For Detection Of Underlying Philadelphia Chromosome-Like (Ph-Like) Events And Therapeutic Targeting In Leukemia

View page
US Patent:
20170298449, Oct 19, 2017
Filed:
Jun 30, 2017
Appl. No.:
15/638926
Inventors:
- Albuquerque NM, US
- Memphis TN, US
- Philadelphia PA, US
I-Ming Chen - Albuquerque NM, US
Kathryn G. Roberts - Memphis TN, US
Huining Kang - Albuquerque NM, US
Richard C. Harvey - Placitas NM, US
International Classification:
C12Q 1/68
Abstract:
The invention provides arrays, systems, devices, methods, computer-readable media and kits that enable expression-based classification of B-precursor acute lymphoblastic leukemia (ALL) as being either responsive or non-responsive to tyrosine kinase inhibitor mono or co-therapy.

Gene Expression Signatures For Detection Of Underlying Philadelphia Chromosome-Like (Ph-Like) Events And Therapeutic Targeting In Leukemia

View page
US Patent:
20140322166, Oct 30, 2014
Filed:
Dec 12, 2012
Appl. No.:
14/364182
Inventors:
- Albuquerque NM, US
- Memphis TN, US
- Philadelphia PA, US
I-Ming Chen - Albuquerque NM, US
Kathryn G. Roberts - Memphis TN, US
Huining Kang - Albuquerque NM, US
Richard C. Harvey - Placitas NM, US
Assignee:
STC. UNM - Albuquerque NM
International Classification:
C12Q 1/68
US Classification:
424 857, 506 16, 506 9
Abstract:
The invention provides arrays, systems, devices, methods, computer-readable media and kits that enable expression-based classification of B-precursor acute lymphoblastic leukemia (ALL) as being either responsive or non-responsive to tyrosine kinase inhibitor mono or co-therapy.
Control profile
Huining Kang from Albuquerque, NM, age ~66 Get Report